Psychedelics Research: What Does Trump's New Executive Order Mean?

The President has cleared the way for research into new mental-health treatments - but experts urge caution

How Ibogaine Became the Darling of the Psychedelic Right

Texas is leading the charge to turn an African psychedelic into a life-saving drug. But will iboga’s historic stewards get a cut?

How Trump's psychedelics executive order could unlock stalled cannabis reform

The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine.
Psychology Today

What the New Executive Order Means for Psychedelics

President Trump's new executive order has drawn major attention to psychedelic treatments for mental health. Here's what patients and families should know.

Psychedelics may soon become easier to get. Is that good?

A psychiatrist explains the benefits and risks.

The Promise and Limits of Trump's Psychedelic Therapy Order

The president's facilitation of research and FDA review could help make psychedelics available to approved patients. But what about everyone else?

7 Best Psychedelic Stocks and ETFs to Buy in 2026

President Trump's executive order is giving psychedelic stocks a boost. These companies are leaders in the industry.